Galactic cosmic rays (GCR) are among the biggest hindrances to crewed space exploration. The ions contributing the most to fluence and absorbed dose in free space are 1H and 4He. In addition, their contribution to dose equivalent increases behind thick shields. In this work, the results of depth-dose measurements performed with high-energy 1H and 4He ions (2 GeV and 480 MeV 1H, and 430 MeV/u 4He) in structural (aluminum alloy), standard (PMMA and high-density polyethylene), innovative (lithium hydride) and in situ (Moon regolith simulant) shielding materials are presented. A strong dose build-up effect, due to target fragments and secondary protons, is observed in the first part of the Bragg curve for all the tested ion beams. The experimental results are compared to the Monte Carlo simulation tools most used for radiation protection in space, i.e., different physics lists of Geant4, PHITS, and FLUKA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1667/RADE-24-00244.1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The use of grocery-sourced real food solutions in sublingual immunotherapy for food allergies.
Ann Allergy Asthma Immunol
March 2025
Division of Allergy, Department of Pediatrics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada; BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Background: Sublingual immunotherapy (SLIT) is a safe, effective therapy for the treatment of food allergy. Studies demonstrating SLIT efficacy have primarily used pharmaceutical glycerinated food extracts for the administration of food allergens, which may limit accessibility due to extract cost and availability.
Objective: To develop novel sample protocols and resources for the preparation of grocery-sourced real food SLIT solutions, which could help more clinicians incorporate food SLIT into their practice and increase accessibility to this treatment.
Toxicokinetic Characterization of Isopropyl Glycidyl Ether in Rat by a Validated LC-APCI-MS/MS Method Using In-Source Derivatization.
Chem Res Toxicol
March 2025
Toxi-Coop Toxicological Research Center, Berlini utca 47-49, Budapest H-1045, Hungary.
Isopropyl glycidyl ether (IPGE) is a member of the large glycidyl ether family frequently used as a reactive diluent during the epoxy resin manufacturing process. Although the toxicity induced by this type of chemical has been investigated in many studies of different aspects (acute, subchronic, genotoxic, reproduction, etc.), there is still little known about their toxicokinetics.
View Article and Find Full Text PDFDose Build-up of High-energy 1H and 4He Ions in Standard, Innovative and In Situ Shielding Materials for Space Radiation: Measurements and Simulations.
Radiat Res
March 2025
Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany.
Galactic cosmic rays (GCR) are among the biggest hindrances to crewed space exploration. The ions contributing the most to fluence and absorbed dose in free space are 1H and 4He. In addition, their contribution to dose equivalent increases behind thick shields.
View Article and Find Full Text PDFSkeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy.
J Cachexia Sarcopenia Muscle
February 2025
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Background: Spinal muscular atrophy (SMA) is a health- and life-limiting neuromuscular disorder. Although varying degrees of mitochondrial abnormalities have been documented in SMA skeletal muscle, the influence of disease progression on pathways that govern organelle turnover and dynamics are poorly understood. Thus, the purpose of this study was to investigate skeletal muscle mitochondria during SMA disease progression and determine the effects of therapeutic modalities on organelle biology.
View Article and Find Full Text PDFOmalizumab with allergen immunotherapy in respiratory & food allergy.
Indian J Tuberc
January 2025
National Allergy Centre, Delhi, India. Electronic address:
Allergen Immunotherapy (AIT) is the only disease modifying treatment option for patient with IgE mediated allergic disorder. Conventional subcutaneous immunotherapy is associated with adverse events during build-up and maintenance phase but cluster allergen immunotherapy with monoclonal anti-IgE antibody (omalizumab) has complementary and synergistic effect. Omalizumab plus AIT can significantly enhance the efficacy, safety, and steroid-sparing effect of AIT by increasing target maintenance dose (TMD) and sustained unresponsiveness (SU) to allergen while decreasing the adverse events and severe systemic reactions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!